This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With two busy 2019 quarters booked, PharmaPackaging Solutions knew it needed to expand capacity quickly. Inventory space was added through more efficient rack management and a new DEA Vault for Schedule II drugs was installed and approved by the DEA. Investments totaling over $2,7 million were made in several areas.
According to the market intelligence firm, automation appeals to drugpackaging and manufacturing firms, thanks to their productivity-boosting potential.
By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The pharmaceutical industry works hard to create cutting-edge drugs to save lives and keep people healthy.
With the growing number of complex therapies that require specialized packaging and handling requirements, selecting the right contract packaging organization (CPO) involves evaluating what services and additional benefits they can bring to your business.
That’s why the drugpackaging process is so important, and must be carried out correctly. Primary packaging is the first step in the drugpackaging process. As the main line of defense between a drug and its environment, primary packaging must be able to prevent contamination and chemical alterations. .
Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. The download contains detailed information on commercial pharmaceutical packaging contractors, and their product and service lines, alongside contact details to aid your hiring decision.
There are plenty of reasons pharma companies have started making this shift. Outsourcing pharmaceutical packaging to contract packaging organizations (CPOs) is a cost-effective way for pharmaceutical companies to bring drugs to market without sacrificing packaging quality. Packaging Innovation.
Hospital Unit Dose (HUD) Packaging. Low Humidity Packaging (we can hold 3% humidity in 70 degrees Fahrenheit). Schedule II drugs in our secure DEA Vault. Heat sealed blister card packaging. The post Domestic CPO Services If You Need US Based Production appeared first on PharmaPackaging Solutions.
Another important factor to take into account when seeking a pharmaceutical packaging partner is regulatory compliance. The post What to Look for in a Pharmaceutical Packaging Company appeared first on PharmaPackaging Solutions. Contact us today at (865) 494-6000 or send an email to marcelo.cruz@tjoapack.com.
Cleanrooms are critical in the development of pharmaceuticals, offering a controlled environment free from contamination to test new drugs and therapeutic devices. Jon Sewell is a Technical Manager at Origin PharmaPackaging, responsible for the Aseptic Filling Program and Special Projects. About the author.
Biopharmaceuticals, also called biologics, are drug products that are manufactured using biological sources. For more information on our biologics packaging options, contact us today at ( 865) 494-6000 or send an email to valarie.leshko@tjoapack.com. appeared first on PharmaPackaging Solutions. Let’s break it down.
Biologics are drug products that are manufactured using materials from living sources. appeared first on PharmaPackaging Solutions. However, they are still new enough that many of us still have unanswered questions. For example, what is the difference between biologics and biosimilars? Let’s talk about it. What are Biologics?
Packaging Provides Product Information. Pharmaceutical packaging is a perfect medium for communicating vital drug facts like dosage instructions and product warnings; it allows patients to use medications in a safe and informed manner. . Pharmaceutical packaging also allows for serialization and aggregation.
Packaging must prevent interactions between the medication and external contaminants, as well as between the drug and its container. Tjoapack employs innovative packaging materials that are inert and non-reactive, ensuring that the medication remains chemically stable.
As a premier provider of medical device packaging solutions, we recognize the prime importance of adhering to global regulations while creating packaging solutions that protect both products and patients. Call us at 865.494.6000 or email solutions@tjoapack.com to begin the journey towards excellence in medical device packaging.
The agency is beginning to see the fruits of its success, with Chinese company WuXi opening its first operation outside of China – a biologics drugs substance facility in Dundalk and Korean company SK Biotek settling at Swords Campus, Dublin. However, attracting Asian investment has not been easy, says Mullen.
On an average, around 50 drugs are approved by the US Food and Drug Administration (US FDA) annually. In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023. Demand Analysis.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content